Oliveto Joseph
President and CEO
Oliveto Joseph has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Oliveto Joseph is listed as President and CEO at Milestone Pharmaceuticals Inc. Inside the rolling window, Oliveto Joseph reported no open-market purchases and 5 open-market sales totaling $556K in MIST. The largest disclosed transaction in the window is a sale of 133,054 MIST shares on Dec 15, 2025, worth $309K.
Companies traded
Other insiders at MIST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$556K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Oliveto Joseph made?
Oliveto Joseph has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Oliveto Joseph trade?
Oliveto Joseph has filed SEC Form 4 disclosures for 1 company, including MIST.
When was Oliveto Joseph's most recent SEC Form 4 filing?
Oliveto Joseph's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Oliveto Joseph's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Oliveto Joseph is listed as President and CEO.
What is Oliveto Joseph's total buy and sell value in the current window?
Inside the rolling retention window, Oliveto Joseph bought $0 and sold $556K based on SEC Form 4 filings.
What was Oliveto Joseph's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 133,054 MIST shares on 2025-12-15, worth $309K, per SEC Form 4 filings.